Prevention of perinatal transmission of hepatitis B virus : prenatal screening of all pregnant women for hepatitis B surface antigen

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Corporate Authors:
  National Center for Infectious Diseases (U.S.). Division of Viral Hepatitis.
• Description:
  In 1995, highly effective inactivated hepatitis A vaccines were first licensed in the United States for preexposure prophylaxis against hepatitis A virus (HAV) among persons aged > or =2 years. In 2005, vaccine manufacturers received Food and Drug Administration approval for use of the vaccines in children aged 12-23 months.
• Subjects:
  Diagnostic Tests, Routine Female Hepatitis B Hepatitis B E Antigens Hepatitis B Surface Antigens Hepatitis B Vaccines Humans Immunoglobulins Infant, Newborn Mass Screening Pregnancy Prenatal Care Risk Factors Viral Hepatitis Vaccines

  More +
• Source:
  MMWR. Morbidity and mortality weekly report. 1988; 37(22):341-6, 351.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print)
• Pubmed ID:
  2967425
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  7 pdf pages
• Volume:
  37
• Issue:
  22
• Collection(s):
  Guidelines and Recommendations Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:79b9c55f853565d62c9b50e0019a802183cf7920b970f1bcde3c84b82a924ab04775dcab5fdb630e8975c67e56acae6ba1847e547729acbd6bdcde455680d76d
• Download URL:
  https://stacks.cdc.gov/view/cdc/7349/cdc_7349_DS1.pdf
• File Type:
  [PDF - 270.69 KB ]